This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Florida International University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2016-2022.
Company Filing History:
3 out of 604 
2 out of 3,690 
Years Active: 2016-2022
Title: **Innovative Contributions of Alexander Agoulnik**
Introduction
Alexander Agoulnik, an accomplished inventor based in Miami, FL, has made significant strides in the field of medical innovations. With a total of three patents to his name, Agoulnik focuses primarily on advancing treatments related to vascular health and receptor modulation.
Latest Patents
Two of Agoulnik's latest patents showcase his commitment to addressing serious health concerns. The first patent, titled "Materials and methods for the treatment of vascular calcification," entails novel molecules, compositions, and methods aimed at treating, preventing, or ameliorating various forms of vascular calcification. This innovative approach employs relaxin-based and epidermal growth factor receptor (EGFR)-based strategies, utilizing RXFP1 agonists and/or EGFR inhibitors.
The second patent, which deals with "Modulators of the relaxin receptor 1," provides valuable insights into the treatment of conditions mediated by the human relaxin receptor 1. It describes various compounds and compositions that can facilitate therapeutic interventions for cardiovascular disease, with a focus on health facets influenced by the receptor.
Career Highlights
Throughout his career, Alexander Agoulnik has contributed to groundbreaking research and innovative developments in the medical field. He has been associated with notable institutions such as the Florida International University Board of Trustees and the United States of America, as represented by the Secretary of the Department of Health and Human Services. His work exemplifies the integration of science and healthcare innovation to improve patient outcomes.
Collaborations
Agoulnik's endeavor in innovation has seen him collaborate with prominent colleagues in the field, including Juan Jose Marugan and Jingbo Xiao. These partnerships have further enriched the depth of research and invention, essential for pushing the boundaries of medical science.
Conclusion
Alexander Agoulnik stands out as a key figure in the realm of medical innovation. His pioneering patents and collaborations reflect a dediсation to improving health through advanced treatments. With a focus on vascular health and receptor modulation, Agoulnik's work continues to pave the way for future innovations in the medical field.